These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19429848)

  • 21. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
    Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O;
    Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
    Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
    Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease.
    Williams LN; Seignourel P; Crucian GP; Okun MS; Rodriguez RL; Skidmore FM; Foster PS; Jacobson CE; Romrell J; Bowers D; Fernandez HH
    Mov Disord; 2007 Jan; 22(1):141-5. PubMed ID: 17089386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease.
    Cohen OS; Vakil E; Tanne D; Nitsan Z; Schwartz R; Hassin-Baer S
    Cogn Behav Neurol; 2007 Mar; 20(1):68-72. PubMed ID: 17356347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of symptoms of depression and anxiety in chronic hemodialysis patients.
    Bossola M; Ciciarelli C; Di Stasio E; Conte GL; Vulpio C; Luciani G; Tazza L
    Gen Hosp Psychiatry; 2010; 32(2):125-31. PubMed ID: 20302985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease.
    Freiheit EA; Hogan DB; Eliasziw M; Patten SB; Demchuk AM; Faris P; Anderson T; Galbraith D; Parboosingh JS; Ghali WA; Knudtson M; Maxwell CJ
    Arch Gen Psychiatry; 2012 Mar; 69(3):244-55. PubMed ID: 22393217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between the regional cerebral blood flow and the cognitive function and anosmia in patients with Parkinson disease and Alzheimer disease].
    Imamura K; Matumoto S; Mabuchi N; Kobayashi Y; Okayasu N; Watanabe K
    Brain Nerve; 2009 Jun; 61(6):683-90. PubMed ID: 19526836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of aging to the severity of different motor signs in Parkinson disease.
    Levy G; Louis ED; Cote L; Perez M; Mejia-Santana H; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Marder K
    Arch Neurol; 2005 Mar; 62(3):467-72. PubMed ID: 15767513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Category verbal fluency predicted changes in behavioral and psychological symptoms of dementia in patients with Alzheimer's disease.
    Tsai CF; Wang SJ; Zheng L; Fuh JL
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):408-14. PubMed ID: 20573053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vulnerability to emotionally negative stimuli in Parkinson's disease: an investigation using the Emotional Stroop task.
    Serra-Mestres J; Ring HA
    Neuropsychiatry Neuropsychol Behav Neurol; 1999 Jan; 12(1):52-7. PubMed ID: 10082333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
    Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
    HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A screening assessment of cognitive impairment in patients with ALS.
    Gordon PH; Wang Y; Doorish C; Lewis M; Battista V; Mitsumoto H; Marder K
    Amyotroph Lateral Scler; 2007 Dec; 8(6):362-5. PubMed ID: 17852014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of depression criteria (DSM-IV) in patients with Parkinson's disease.
    Gómez-Esteban JC; Tijero B; Somme J; Bilbao I; Fernández J; Boyero S; Velasco F; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2009 Oct; 111(8):665-9. PubMed ID: 19589638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of cognitive impairment in a population of patients with Parkinson's disease by means of the mini mental Parkinson test].
    Parrao-Díaz T; Chaná-Cuevas P; Juri-Claverías C; Kunstmann C; Tapia-Núñez J
    Rev Neurol; 2005 Mar 16-31; 40(6):339-44. PubMed ID: 15795869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases].
    Xiao SF; Xue HB; Li GJ; Li CB; Wu WY; Zhang MY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1441-6. PubMed ID: 16842692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD).
    Oh JY; Kim YS; Choi BH; Sohn EH; Lee AY
    Arch Gerontol Geriatr; 2009; 49(3):351-4. PubMed ID: 19136159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing cognition in Parkinson disease: use of the cognitive linguistic quick test.
    Parashos SA; Johnson ML; Erickson-Davis C; Wielinski CL
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):228-34. PubMed ID: 19666882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age.
    Vinkers DJ; Stek ML; van der Mast RC; de Craen AJ; Le Cessie S; Jolles J; Westendorp RG; Gussekloo J
    Neurology; 2005 Jul; 65(1):107-12. PubMed ID: 16009894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.